SP1 and cholangiocarcinoma: Sp1 can bind lncRNA sprouty receptor tyrosine kinase signaling antagonist 4–intronic transcript 1 (SPRY4-IT1) promoter and activate its transcription, thereby playing a carcinogenic role in cholangiocarcinoma [37].